We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
988

Sector Composition

Rank Sector Weight
1 Technology 6.22%
2 Financials 6.16%
3 Industrials 5.09%
4 Consumer Discretionary 4.89%
5 Healthcare 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNST icon
1526
CALL
Monster Beverage
MNST
$91.7B
$11M 0.01%
695,600
+112,800
+19% +$1.69M
GPN icon
1527
Global Payments
GPN
$24.6B
$11M 0.01%
109,597
+44,589
+69% +$4.46M
EXPR
1528
DELISTED
Express, Inc.
EXPR
$11M 0.01%
54,100
+3,060
+6% +$502K
ETFC
1529
PUT
DELISTED
E*Trade Financial Corporation
ETFC
$11M 0.01%
221,500
+88,100
+66% +$4.04M
STLD icon
1530
CALL
Steel Dynamics
STLD
$36.7B
$11M 0.01%
254,500
+75,900
+42% +$2.92M
SYNH
1531
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$11M 0.01%
251,357
+138,235
+122% +$6.46M
USG
1532
CALL
DELISTED
Usg
USG
$10.9M 0.01%
283,900
+78,200
+38% +$2.75M
FITB
1533
PUT
Fifth Third Bancorp
FITB
$52.7B
$10.9M 0.01%
360,500
+152,700
+73% +$4.45M
ELV icon
1534
CALL
Elevance Health
ELV
$86.8B
$10.9M 0.01%
48,600
-9,800
-17% -$2.09M
VRTX icon
1535
CALL
Vertex Pharmaceuticals
VRTX
$128B
$10.9M 0.01%
72,900
-29,900
-29% -$4.43M
SCHW
1536
PUT
Charles Schwab
SCHW
$192B
$10.9M 0.01%
212,400
+66,500
+46% +$3.12M
VIAB
1537
PUT
DELISTED
Viacom Inc. Class B
VIAB
$10.9M 0.01%
354,100
+84,700
+31% +$2.3M
AFG icon
1538
American Financial Group
AFG
$12.1B
$10.9M 0.01%
100,430
+63,895
+175% +$6.71M
OCLR
1539
DELISTED
Oclaro Inc.
OCLR
$10.9M 0.01%
1,616,487
-1,647,243
-50% -$12.2M
PCRX icon
1540
Pacira BioSciences
PCRX
$917M
$10.9M 0.01%
238,567
+177,445
+290% +$7.03M
STMP
1541
CALL
DELISTED
Stamps.com, Inc.
STMP
$10.9M 0.01%
57,900
-12,800
-18% -$2.47M
LNG icon
1542
Cheniere Energy
LNG
$56.1B
$10.9M 0.01%
202,033
-22,789
-10% -$1.1M
UPRO icon
1543
CALL
ProShares UltraPro S&P 500
UPRO
$5.82B
$10.9M 0.01%
465,600
+177,600
+62% +$3.82M
ACIW icon
1544
ACI Worldwide
ACIW
$5.4B
$10.9M 0.01%
479,502
-95,725
-17% -$2.22M
EWY icon
1545
CALL
iShares MSCI South Korea ETF
EWY
$27.8B
$10.9M 0.01%
145,000
-35,100
-19% -$2.6M
BDC icon
1546
Belden
BDC
$5.31B
$10.9M 0.01%
140,767
+108,569
+337% +$8.97M
ACHC icon
1547
Acadia Healthcare
ACHC
$2.87B
$10.9M 0.01%
332,821
+199,090
+149% +$6.9M
WW
1548
PUT
DELISTED
WW International
WW
$10.8M 0.01%
245,000
+28,500
+13% +$1.3M
MTOR
1549
CALL
DELISTED
MERITOR, Inc.
MTOR
$10.8M 0.01%
461,200
+279,500
+154% +$7.02M
BZUN
1550
PUT
Baozun
BZUN
$165M
$10.8M 0.01%
342,800
+279,700
+443% +$9.03M

Similar funds

Citadel Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Citadel Advisors opened 1,440 new positions and closed 988 in Q4 2017.
  • Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.